BRT PROXY STATEMENT REVISED NO. 1

Company

BioRestorative Therapies, Inc.

Filed

October 23, 2012

Period of Report

October 22, 2012

Accession Number

0001021771-12-000053

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →